Showing results (131-140 of 226) with videos related to

Sort By:
Pageof 23
PNAS Nexus|July 28, 2022
Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathwaysEddy H C Wang, Isha Monga, Brigitte N Sallee, et al.
Nature Medicine|December 20, 2011
Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathwayHyunkyung Jeong, Dena E Cohen, Libin Cui, et al.
The Journal of Investigative Dermatology|September 16, 2023
Inborn Errors of Immunity Contribute to the Burden of Skin Disease and Create Opportunities for Improving the Practice of DermatologyAnnelise Colvin, Soundos Youssef, Heeju Noh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
GAB2 amplifications refine molecular classification of melanomaKaren A Chernoff, Lindsey Bordone, Basil Horst, et al.
Gene|December 13, 2021
Expression dynamics of the immune mediators ARG1, TBET, CIITA, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapyMaría Jazmín Toloza, Yesica Bestach, Marco Lincango-Yupanki, et al.
Aging Cell|September 20, 2007
SIRT1 transgenic mice show phenotypes resembling calorie restrictionLaura Bordone, Dena Cohen, Ashley Robinson, et al.
Brazilian Journal of Otorhinolaryngology|March 7, 2019
Molecular study of hearing loss in Minas Gerais, BrazilRaíssa de Oliveira Aquino Schüffner, Karla Lima Nascimento, Fábio André Dias, et al.
International Journal of Geriatric Psychiatry|June 16, 2012
Management of apathy in nursing homes using a teaching program for care staff: the STIM-EHPAD studyElsa Leone, Audrey Deudon, Murielle Bauchet, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
Endocrine-Related Cancer|September 28, 2011
MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cellsPatrick Brest, Sandra Lassalle, Veronique Hofman, et al.
Pageof 23